Nasdaq

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for prostate tissue ablation. The clearance for the NanoKnife System for prostate ...
Nasdaq

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Seeking Alpha

AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
WFLA News Channel 8

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...
KHON2

Minimally Invasive, Outpatient Treatment Designed for Quick Recovery and Low Risk of Unwanted ED and UI Side Effects

IRVINE, Calif. and MIAMI, Jan. 31, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced the full twenty ...
WDAF-TV

CORRECTION: CLS Americas and Unio Health Partners Announce Clinical Study “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”

IRVINE, Calif. and SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- A correction has been issued for a release issued under the same headline earlier today by Clinical Laserthermia Systems Americas, Inc.
FierceBiotech

Francis Medical collects $80M to carry water vapor ablation for prostate cancer to the FDA

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...
Becker's Hospital Review

FDA OKs updated prostate tissue ablation device

Charlotte, N.C.-based SonaCare Medical earned clearance from the Food and Drug Administration for a new version of its Sonablate device. Sonablate, intended for use in the focused ablation of prostate ...

Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029 | MarketsandMarkets™

Advancements in ablation technologies, expanding healthcare access in emerging economies, and strategic investments by global ...
MarketWatch

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish(R) Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

The MarketWatch News Department was not involved in the creation of this content. MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing ...